Home › Funds › Transmarket Holdings LP › ESPR

Transmarket Holdings LP position in ESPR

ESPERION THERAPEUTICS INC NE

Transmarket Holdings LP reported holding 1,590,721 shares of ESPR (ESPERION THERAPEUTICS INC NE) in its Q2 2026 13F filing — a position valued at US$5.0M, representing 3.69% of its reported portfolio and ranking #12 among its reported holdings. Transmarket Holdings LP first reported this position in Q2 2026.

Latest position (Q2 2026)1.59M sh
Reported value held$5.03M
Portfolio Weight3.69%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

How Transmarket Holdings LP's ESPR position evolved

Transmarket Holdings LP first disclosed a stake in ESPR in Q2 2026 at 1,590,721 shares (US$5.0M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.59M $5.03M New

About ESPR and 13F data

ESPR (ESPERION THERAPEUTICS INC NE) is a company whose sector is not yet classified in our data. 41 other funds we track also report a position in ESPR — the largest reported positions include GLAZER CAPITAL, LLC (US$70.8M), ODDO BHF ASSET MANAGEMENT SAS (US$15.8M), Beryl Capital Management LLC (US$14.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ESPR

All ESPR fund holders →